You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

RAPLON Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Raplon patents expire, and when can generic versions of Raplon launch?

Raplon is a drug marketed by Organon Usa Inc and is included in one NDA.

The generic ingredient in RAPLON is rapacuronium bromide. Additional details are available on the rapacuronium bromide profile page.

Summary for RAPLON
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 29
Patent Applications: 553
DailyMed Link:RAPLON at DailyMed
Drug patent expirations by year for RAPLON

US Patents and Regulatory Information for RAPLON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc RAPLON rapacuronium bromide INJECTABLE;INJECTION 020984-001 Aug 18, 1999 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Organon Usa Inc RAPLON rapacuronium bromide INJECTABLE;INJECTION 020984-002 Aug 18, 1999 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for RAPLON

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc RAPLON rapacuronium bromide INJECTABLE;INJECTION 020984-001 Aug 18, 1999 ⤷  Try a Trial ⤷  Try a Trial
Organon Usa Inc RAPLON rapacuronium bromide INJECTABLE;INJECTION 020984-002 Aug 18, 1999 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for RAPLON

See the table below for patents covering RAPLON around the world.

Country Patent Number Title Estimated Expiration
Norway 931466 ⤷  Try a Trial
Hungary 9301173 ⤷  Try a Trial
Japan H07267984 MONO-QUATERNARY SALT DERIVATIVE OF 2,16-BISPIPERIDINYLANDROSTANE ⤷  Try a Trial
Czech Republic 286728 Monoquaternary derivatives of 2,16-bispiperidinylandrostane, their use and pharmaceutical preparation based thereon ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.